Free Trial
OTCMKTS:BIOQ

Bioqual (BIOQ) Stock Price, News & Analysis

Bioqual logo
$45.00 0.00 (0.00%)
As of 05/29/2025

About Bioqual Stock (OTCMKTS:BIOQ)

Key Stats

Today's Range
$45.00
$45.00
50-Day Range
$45.00
$60.00
52-Week Range
$45.00
$72.50
Volume
N/A
Average Volume
608 shs
Market Capitalization
$40.23 million
P/E Ratio
N/A
Dividend Yield
1.11%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Receive BIOQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter.

BIOQ Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
BIOQUAL Announces Changes to Board of Directors
BIOQUAL Declares Dividend
See More Headlines

BIOQ Stock Analysis - Frequently Asked Questions

Bioqual's stock was trading at $66.10 at the start of the year. Since then, BIOQ stock has decreased by 31.9% and is now trading at $45.00.
View the best growth stocks for 2025 here
.

Bioqual, Inc. (OTCMKTS:BIOQ) issued its earnings results on Friday, April, 11th. The company reported $1.05 earnings per share (EPS) for the quarter. The business earned $14.03 million during the quarter. Bioqual had a negative net margin of 5.54% and a negative trailing twelve-month return on equity of 7.50%.

Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Zymergen (ZY), Allied Gaming & Entertainment (AGAE), Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO) and Berkeley Energia (BKY).

Company Calendar

Last Earnings
4/11/2025
Today
5/31/2025
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
OTCMKTS:BIOQ
Fax
N/A
Employees
114
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$480 thousand
Pretax Margin
-8.03%

Debt

Sales & Book Value

Annual Sales
$58.59 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
543,000
Market Cap
$40.23 million
Optionable
Not Optionable
Beta
-0.09

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:BIOQ) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners